TPC - Aeterna Laboratories (en francais)

Since Industry Minister Emerson has decided not to release any information or details on what is going on with the TPC program, I'm left to my own devices. I'm going to start profiling some of the TPC companies listed in the Annual Reports on the Industry Canada - TPC website.

From the 1999 - 2000 Annual Report

AETERNA LABORATORIES INC.
More effective treatments for cancer, psoriasis and macular degeneration (a severe impairment of vision) may soon be a reality, thanks to three projects by Quebec City-based Aeterna Laboratories Inc. to develop new treatment approaches. The company’s treatment uses angiogenesis inhibitors extracted from shark cartilage, which prevent the formation of the oxygen-giving blood vessels that feed tumours and other growing cells. Without oxygen, these cells starve and die. Because this therapy is non-toxic, it may be used in conjunction with other therapies. If successful, this treatment could increase the quality of life of millions of people around the world.

TPC approved repayable R&D investments:
cancer treatment – $9.9 million;
psoriasis treatment –$9.6 million;
macular degeneration treatment – $9.8 million

Minister - Alan Rock

Registered Lobbyist - David Dingwall 1998/11/25 - 2003/03/21

Aeterna Laboratories Federal Political Contributions 1996 - 2004 (TPC started in 96)
1996 - 0
1997 - 0
1998 - $5,000 Liberal Party of Canada
1999 - 0 (TPC was virtually shut down this year due to a WTO ruling)
2000 - $4,323.90 Liberal Party of Canada
2001 - $4346.30 Liberal Party of Canada
2002 - $1,315.36 Liberal Party of Canada
2003 - $856.16 Liberal Party of Canada
2004 - 0

(cross posted from Technoscam)